Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer

Abstract

Alternol interacts with multiple Krebs cycle enzymes, resulting in reduced mitochondrial respiration and ATP production in prostate cancer cells and xenograft tissues, providing a novel therapeutic strategy for prostate cancer treatment.